Autres langues Xcelerate Inc.

Actions

XCRT

US98401T1051

Marché Fermé - OTC Markets Autres places de cotation 21:53:54 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,0335 ^USD	+1,52 %		-3,18 %	-6,94 %

2023	Xcelerate Inc. a déposé une demande d'introduction en bourse pour un montant de 17,25 millions de dollars.	CI
2023	Xcelerate Inc. annonce la publication de ses deux demandes de brevet d'utilité	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report	01/05
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence	26/03
Xcelerate, Inc. Announces Participation in The Microcap Conference	19/01
Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	13/11
Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	24/10/23
Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22/09/23
Xcelerate Announces Marketing Agreement with ProductSector, LLC	08/08/23
Xcelerate, Inc. Acquires a Majority Interest in ESN Group	26/07/23
Xcelerate Inc. acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.	24/07/23
Xcelerate Inc. completed the acquisition of an unknown majority stake in ESN Group, Inc.	20/07/23
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	28/04/23
Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board	01/02/23
Xcelerate Inc. entered into a letter of intent to acquire an unknown majority stake in ESN Group, Inc.	17/01/23
Tenet Announces Partnership with Xcelerate Auto to Offer New Warranty Options	28/09/22
Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/09/22
Xcelerate : Announces Uplisting to OTCQB Market	01/08/22
Xcelerate : OTCQB Certification	20/07/22
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT	23/05/22
Michael O’Shea CEO, Releases Shareholder Update	09/03/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Xcelerate Inc.

Actions

XCRT

US98401T1051

Autres langues

Filtres